Consolidated Statements of Earnings
| For the years ended December 31 (In thousands, except per share data) | 2011 | 2010 | 2009 |
|---|---|---|---|
| Net sales | $2,054,130 | $1,893,134 | $1,809,690 |
| Cost of sales | (1,378,012) | (1,271,381) | (1,214,159) |
| Gross profit | $676,118 | $621,753 | $595,531 |
| Research and development expenses | (62,115) | (54,131) | (54,645) |
| Selling expenses | (119,438) | (111,773) | (106,187) |
| General and administrative expenses | (289,609) | (276,026) | (265,380) |
| Operating income | $204,956 | $179,823 | $169,319 |
| Interest expense | (20,834) | (22,107) | (25,066) |
| Other income, net | 867 | 579 | 1,006 |
| Earnings before income taxes | $184,989 | $158,295 | $145,259 |
| Provision for income taxes | (54,566) | (51,697) | (50,038) |
| Net earnings | $130,423 | $106,598 | $95,221 |
| Net earnings per share: | |||
| Basic earnings per share | $2.81 | $2.33 | $2.10 |
| Diluted earnings per share | $2.77 | $2.30 | $2.08 |
| Weighted average shares outstanding: | |||
| Basic | 46,372 | 45,823 | 45,237 |
| Diluted | 47,013 | 46,322 | 45,695 |